ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the recipient of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totaling 8,812 shares, a decrease of 43.0% from the August 15th total of 15,453 shares. Currently, 1.1% of the company’s shares are sold short. Based on an average daily volume of 16,290 shares, the days-to-cover ratio is presently 0.5 days.

Institutional Inflows and Outflows

An institutional investor recently raised its stake in ProShares Ultra Nasdaq Biotechnology stock. Kaizen Financial Strategies boosted its stake in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) by 4.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,565 shares of the exchange traded fund’s stock after purchasing an additional 250 shares during the quarter. Kaizen Financial Strategies owned about 0.60% of ProShares Ultra Nasdaq Biotechnology worth $483,000 as of its most recent filing with the SEC.

ProShares Ultra Nasdaq Biotechnology Trading Up 1.8%

NASDAQ BIB opened at $111.73 on Tuesday. The business’s 50-day moving average price is $108.74 and its 200 day moving average price is $92.85. ProShares Ultra Nasdaq Biotechnology has a twelve month low of $55.34 and a twelve month high of $126.40. The company has a market capitalization of $8.94 million, a PE ratio of 20.68 and a beta of 1.22.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.